Variable | Nature | BeEOT | BEOT | MEOT | Reference level | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
O-RADS MRI | 2 | 3 | 4 | 5 | 2 | 3 | 4 | 5 | 3 | 4 | 5 | 0–5 | |
No. (%) | 16 (29.63) | 36 (66.67) | 1 (1.85) | 1 (1.85) | 1 (0.96) | 53 (50.96) | 40 (38.46) | 10 (9.62) | 28 (13.80) | 89 (43.84) | 86 (42.36) | / | |
Menopausal status | Premenopausal | 10 | 25 | 1 | 1 | 0 | 40 | 37 | 9 | 18 | 45 | 32 | / |
Postmenopausal | 6 | 11 | 0 | 0 | 1 | 13 | 3 | 1 | 10 | 44 | 54 | ||
Pathological type | Serous | 10 | 9 | 1 | 0 | 0 | 36 | 27 | 4 | 17 | 40 | 65 | / |
Mucinous | 4 | 25 | 0 | 0 | 1 | 10 | 9 | 4 | 5 | 9 | 1 | ||
Endometrioid | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 2 | 20 | 6 | ||
Clear cell | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 19 | 11 | ||
Serous-mucinous | 2 | 2 | 0 | 0 | 0 | 6 | 4 | 1 | 1 | 1 | 1 | ||
Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | ||
FIGO stage | I | / | 1 | 47 | 31 | 8 | 13 | 40 | 14 | I-IV | |||
II | 0 | 2 | 1 | 0 | 3 | 23 | 9 | ||||||
III-IV | 0 | 4 | 8 | 2 | 12 | 26 | 63 |